Dyslipidemia Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CBAY | A | CymaBay Therapeutics Inc. | 0.00 | |
VKTX | C | Viking Therapeutics, Inc. | 3.11 | |
MDGL | C | Madrigal Pharmaceuticals, Inc. | 4.52 | |
ABT | D | Abbott Laboratories | 1.78 | |
ARGX | D | argenx SE | 0.26 | |
IONS | D | Ionis Pharmaceuticals, Inc. | 1.25 |
Related Industries: Biotechnology Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IHI | C | iShares U.S. Medical Devices ETF | 16.8 | |
EWK | B | iShares MSCI Belgium Capped Investable Market Index Fund | 6.71 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 6.7 | |
ULTY | F | Tidal Trust II YieldMax Ultra Option Income Strategy ETF | 5.86 | |
PJP | B | PowerShares Dynamic Pharmaceuticals | 5.49 |
Compare ETFs
Related Industries:
Biotechnology
Medical Devices
- Dyslipidemia
Dyslipidemia is an abnormal amount of lipids (e.g. triglycerides, cholesterol and/or fat phospholipids) in the blood. In developed countries, most dyslipidemias are hyperlipidemias; that is, an elevation of lipids in the blood. This is often due to diet and lifestyle. Prolonged elevation of insulin levels can also lead to dyslipidemia. Likewise, increased levels of O-GlcNAc transferase (OGT) may cause dyslipidemia.
Popular Now
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles